Literature DB >> 2527892

Depression among patients with a chief complaint of chronic fatigue.

P Manu1, D A Matthews, T J Lane, H Tennen, V Hesselbrock, R Mendola, G Affleck.   

Abstract

The prevalence of mood disorders among patients with chronic fatigue was examined in a group of 100 adults who had experienced fatigue symptoms for an average of 13 years. Patients received a comprehensive history, physical and laboratory evaluation and completed the National Institute of Mental Health Diagnostic Interview Schedule and the Beck Depression Inventory (BDI). Among 44 patients with depressive illness, the onset of their first depressive episode was strongly associated with and preceded the onset of chronic fatigue. The BDI, fatigue history, demographic factors, and findings from the physical examination and laboratory had only modest success in discriminating those patients with depressive illness from other patients. We conclude that depressive illness is an important precursor of chronic fatigue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527892     DOI: 10.1016/0165-0327(89)90039-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  Antidepressant therapy in the chronic fatigue syndrome.

Authors:  S Lynch; R Seth; S Montgomery
Journal:  Br J Gen Pract       Date:  1991-08       Impact factor: 5.386

2.  Investigating fatigue of less than 6 months' duration. Guidelines for family physicians.

Authors:  M Godwin; D Delva; K Miller; J Molson; N Hobbs; S MacDonald; C MacLeod
Journal:  Can Fam Physician       Date:  1999-02       Impact factor: 3.275

3.  Follow up of patients presenting with fatigue to an infectious diseases clinic.

Authors:  M Sharpe; K Hawton; V Seagroatt; G Pasvol
Journal:  BMJ       Date:  1992-07-18

Review 4.  Gray matter volumes in patients with chronic fatigue syndrome.

Authors:  Le-Wei Tang; Hui Zheng; Liang Chen; Si-Yuan Zhou; Wen-Jing Huang; Ying Li; Xi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.